Department Of Integrative Immunobiology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and.

Anixa biosciencesAmit kumarJoser conejo garciaMike catelaniAnixa biosciences incWistar instituteDepartment of integrative immunobiologyDuke university school of medicineMoffitt cancer centerMoffitt cancerIntegrative immunobiologyDuke university schoolFollicle stimulating hormone receptor mediatedCleveland clinicLooking statementsPrivate securities litigation reform act

Duke Flags Lowered: Thomas Tedder, Inaugural Chair of Immunology, Dies

Duke Flags Lowered: Thomas Tedder, Inaugural Chair of Immunology, Dies
duke.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duke.edu Daily Mail and Mail on Sunday newspapers.

Thomasf tedderTodd leovicMary klotmanAlter geller distinguished professor for researchDepartment of immunologySchool of medicineDepartment of integrative immunobiologyMedicine fridayAlter geller distinguished professorIntegrative immunobiology

Innovative antibody method targets deep-rooted cancer mutations: Research

Innovative antibody method targets deep-rooted cancer mutations: Research
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

Jose ramon conejo garciaCarmen maria anandonSubir biswasGunjan mundalDuke cancer instituteDuke university school of medicineH lee moffitt cancer centerDepartment of integrative immunobiologyResearch instituteCell pressDuke university schoolDuke scienceMoffitt cancer centerDuke cancer

Antibody Targets Deep-Seated KRAS Cancer Mutations

Immunologist Jose R. Conejo-Garcia, MD, PhD, unveils an antibody that successfully targets once-untreatable KRAS cancer mutations.

Pauloc rodriguezCarlym harroXiaoping yuLuisu lopez bailonCarmen maria anadonJohnj powersRichardoa chaurioJose ramon conejo garciaKay hanggiSubir biswasPatrick innarmaratoBradforda perezGunjan mundalJoseph johnsonTylerj curielKimberlyb sprenger

How innovative antibody approach targets deep-rooted cancer mutations: Study

The study shows a cancer treatment strategy focused on the use of IGA antibodies that can target and kill tumor-promoting molecules found in cancer cells. | Health

India generalSubir biswasCarmen maria anandonGunjan mundalJose ramon conejo garciaDepartment of integrative immunobiologyH lee moffitt cancer centerDuke university school of medicineDuke cancer instituteResearch instituteCell pressDuke university schoolDuke scienceMoffitt cancer centerDuke cancerHindustan times